The Valley Desk

NCT06739122 · Interventional trial

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Overall registry status Recruiting

Phase 3

Conditions Type 2 Diabetes

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov